Fast-food chain Wendy’s (NASDAQ:WEN) will be announcing earnings results this Friday before market open. Here’s what investors should know.
Wendy's beat analysts’ revenue expectations by 3.1% last quarter, reporting revenues of $549.5 million, down 3% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts’ EBITDA estimates and a solid beat of analysts’ revenue estimates.
Is Wendy's a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Wendy’s revenue to decline 6.6% year on year to $536.3 million, a reversal from the 6.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.14 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Wendy's has missed Wall Street’s revenue estimates four times over the last two years.
Looking at Wendy’s peers in the traditional fast food segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Yum China delivered year-on-year revenue growth of 8.8%, beating analysts’ expectations by 3.9%, and Yum! Brands reported revenues up 6.4%, topping estimates by 2.7%. Yum China traded up 9.7% following the results while Yum! Brands was also up 1.5%.
Read our full analysis of Yum China’s results here and Yum! Brands’s results here.
Debates over possible tariffs and corporate tax adjustments have raised questions about economic stability in 2025. While some of the traditional fast food stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. Wendy's is down 5% during the same time and is heading into earnings with an average analyst price target of $9.38 (compared to the current share price of $7.88).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
/Pfizer%20Inc_%20logo%20sign-by%20JHVEPhoto%20via%20iStock.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
